Related references
Note: Only part of the references are listed.Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
Amy G. Feldman et al.
JOURNAL OF PEDIATRICS (2020)
Severe Acute Liver Injury Following Therapeutic Doses of Acetaminophen in a Patient With Spinal Muscular Atrophy
Thomas Theo Brehm et al.
AMERICAN JOURNAL OF THERAPEUTICS (2019)
Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
Marc-Olivier Deguise et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
Basil T. Darras et al.
CNS DRUGS (2019)
Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer
Steven Pipe et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
Christian Hinderer et al.
HUMAN GENE THERAPY (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Adeno-Associated Virus Gene Therapy for Liver Disease
Lisa M. Kattenhorn et al.
HUMAN GENE THERAPY (2016)
Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy
Shi-Yan Ng et al.
CELL STEM CELL (2015)
Spectrum of Neuropathophysiology in Spinal Muscular Atrophy Type I
Brian N. Harding et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy
Sarah Tisdale et al.
JOURNAL OF NEUROSCIENCE (2015)
SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA
W. David Arnold et al.
MUSCLE & NERVE (2015)
Observational study of spinal muscular atrophy type I and implications for clinical trials
Richard S. Finkel et al.
NEUROLOGY (2014)
Spinal Muscular Atrophy: Journeying From Bench to Bedside
Tomoyuki Awano et al.
NEUROTHERAPEUTICS (2014)
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72 400 specimens
Elaine A. Sugarman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks
Zarazuela Zolkipli et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2012)
Spinal Muscular Atrophy A Timely Review
Stephen J. Kolb et al.
ARCHIVES OF NEUROLOGY (2011)
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
G. P. Aithal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
New insights on the evolution of the SMN1 and SMN2 region:: simulation and meta-analysis for allele and haplotype frequency calculations
S Ogino et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Drug therapy: Neonatal hyperbilirubinemia.
PA Dennery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
